Pharmafile Logo
Pharmafocus logo
Advanced Search
pfizerbrussels

Pfizer to acquire Anacor in $5.2 billion deal

May 16, 2016
Manufacturing and Production, Sales and Marketing 5.2 billion, FDA, Pfizer, acquisition, anacor, crisaborole, merger

Pfizer (NYSE: PFE) has acquired Anacor Pharmaceuticals (NASDAQ: ANAC) in a deal worth around $5.2 billion, or $99.25 per share. …

News
mylan_building

Mylan to buy Renaissance’s dermatology business for up to $1 billion

May 16, 2016
Research and Development, Sales and Marketing Mylan, generics, merger and acquisition

Generics maker Mylan (Nasdaq: MYL) has agreed to buy skincare products from Renaissance Acquisition Holdings for up to $1 billion. …

News
sanofi_hq__boetie_hall

Sanofi to replace entire Medivation board to drive sale, according to reports

May 16, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Medivation, Sanofi, replace board, takeover

Reports have emerged that Sanofi is looking to step up its efforts to take over oncology firm, Medivation, as it …

News
stocks1

Weekly Movers: Teva, Midatech, Allergan…

May 16, 2016
Research and Development, Sales and Marketing Allergan, Ariad Pharmaceuticals, Lundbeck, Midatech Pharma, Stock, Teva Pharmaceutical, markets

We have hit the tail end of the earnings season and the near last batch of movers follow result pronouncements …

Feature
174571_1

Novartis says trials show its COPD drug more effective versus GSK’s Seretide

May 16, 2016
Research and Development, Sales and Marketing GSK, Novartis, drug trial, research

Swiss drug firm Novartis (VTX: NOVN) said its asthma drug showed efficacy over GlaxoSmithKline’s (LSE: GSK) medicine in a comparison …

News
trials

Eisai granted additional indication for Lenvima in renal cell carcinoma

May 16, 2016
Sales and Marketing Eisai, additional indication, renal cell carcinoma

Eisai has announced that it has received approval from the US Food and Drug Administration (FDA) for an additional indication …

News
pfizerbrussels

Pfizer presents positive results in meningococcal disease late-stage trials

May 13, 2016
Research and Development Pfizer, Vaccine, late stage trials, meningococcal disease

Pfizer (NYSE: PFE) has announced results from two pivotal late-stage trials demonstrating the immunogenicity of Trumenba against invasive meningococcal B …

News

Clinical Trials Equipment Supplier Woodley Equipment Exhibiting at Outsourcing in Clinical Trials East Coast 2016

May 13, 2016

Woodley Equipment Company Limited is exhibiting at Outsourcing in Clinical Trials East Coast 2016.  The event is taking place on …

News
Press release

Woodley Equipment Company Limited UK Office

May 13, 2016

Woodley Equipment Company Limited  UK Office 

News
Press release
doc_writing

US pass new laws to combat opioid epidemic

May 13, 2016
Medical Communications, Sales and Marketing US, epidemic, fight back, new laws, opioids, reverse

The US has passed new laws that will seek to combat the current epidemic of opioids across the country. The …

News
lab

EU approves Idelvion for haemophilia B treatment

May 13, 2016
Medical Communications, Research and Development CSL, EU, Idelvion, approval, haemophilia B

The European Commission has approved Idelvion, coagulation Factor IX (recombinant) for the treatment and prophylaxis of bleeding in patients with …

News
sanofi_pasteur_scientist

Sanofi Files Hart-Scott-Rodino notification for Medivation acquisition

May 13, 2016
Medical Communications, Sales and Marketing M&A, MA, Medivation, Sanofi, deal

French drugmaker Sanofi (Euronext: SAN) on Friday said it has filed a premerger notification with the US Department of Justice Antitrust …

News
biogen_logo

Sobi, Biogen’s haemophilia B therapy gets European approval

May 13, 2016
Medical Communications, Research and Development, Sales and Marketing Biogen, haemophilia B, orphan designation, regulation, sobi

Sobi (STO: SOBI) and Biogen (Nasdaq: BIIB) on Friday said the European Commission has approved their drug to treat haemophilia B. The …

News

Bayer terminates clinical trial for hypertension due to safety concerns

May 13, 2016
Medical Communications, Research and Development Bayer, clinical trial, deaths, pulmonary hypertension, riociguat, safety concerns

Bayer has terminated a Phase II trial evaluating riociguat in patients with pulmonary hypertension due to fears raised by an …

News
james_kehoe

Takeda appoints new chief financial officer

May 12, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, cfo, james kehoe

Takeda Pharmaceuticals has named James Kehoe its new chief financial officer. He will begin the role on June 15 2016, …

Appointment

Almost 9 in 10 CCGs not implementing NICE guidelines on antibiotic resistance

May 12, 2016
Research and Development, Sales and Marketing CCGs, NICE, antibiotic resistance, failure

The Patients Association has called on all Clinical Commissioning Groups (CCGs) to implement the National Institute for Health and Care …

News

BMS says Nice refuses backing for its immunotherapy Opdivo to treat lung cancer

May 12, 2016
Medical Communications, Research and Development, Sales and Marketing

The National Institute for Health and Care Excellence (Nice) has rejected US pharma firm Bristol-Myers Squibb’s (NYSE: BMY) immune-oncology drug …

News

Multiple myeloma treatment from BMS and AbbVie scores EU approval

May 12, 2016
Research and Development, Sales and Marketing AbbVie, BMS, EMA, EU, Empliciti, approval, bristl-myers squibb, elotuzumab, multiple myeloma

Bristol-Myers Squibb (NYSE: BMY) and AbbVie (NYSE: ABBV) have announced that the European Commission has approved Empliciti (elotuzumab) for the …

News
lilly_entrance_web

FDA issues warning about rare, but serious, side effect in Lilly antipsychotic drug

May 12, 2016
Medical Communications, Sales and Marketing Eli Lilly, FDA, anti-psychotic, boxed warning, lilly, olanzapine, skin condition

The US Food and Drug Administration (FDA) has issued a new warning to all drug labels for Eli Lilly’s antipsychotic …

News
azhqlondonweb

AstraZeneca says its trial drug for thyroid cancer granted US FDA orphan drug designation

May 12, 2016
Research and Development, Sales and Marketing AstraZeneca, Orphan Drug Designation, US FDA, drug trial, regulation

AstraZeneca (LSE: AZN) on Thursday said the US Food and Drug Administration (FDA) has granted Orphan Drug Designation its trial …

News
The Gateway to Local Adoption Series

Latest content

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026

Study explores speech as marker in rare neurodegenerative disease

April 27, 2026

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026